Page 234 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 234

190         SEcTioN ii    Microbiology  ` microbiology—aNtimicrobials                                                                                           Microbiology  ` microbiology—aNtimicrobials





               Carbapenems           Doripenem, Imipenem, Meropenem, Ertapenem (DIME antibiotics are given when there is a
                                       10/10 [life-threatening] infection).

                mecHaNism            Imipenem is a broad-spectrum, β-lactamase–  With imipenem, “the kill is lastin’ with
                                      resistant carbapenem. Always administered   cilastatin.”
                                      with cilastatin (inhibitor of renal      Newer carbapenems include ertapenem (limited
                                      dehydropeptidase I) to  inactivation of drug   Pseudomonas coverage) and doripenem.
                                      in renal tubules.
                cliNical Use         Gram ⊕ cocci, gram ⊝ rods, and anaerobes.
                                      Wide spectrum and significant side effects
                                      limit use to life-threatening infections or
                                      after other drugs have failed. Meropenem
                                      has a  risk of seizures and is stable to
                                      dehydropeptidase I.

                aDVerse eFFects      GI distress, rash, and CNS toxicity (seizures) at
                                       high plasma levels.
                mecHaNism oF resistaNce  Inactivated by carbapenemases produced by,
                                       eg, K pneumoniae, E coli, E aerogenes.



               Monobactams           Aztreonam
                mecHaNism            Less susceptible to β-lactamases. Prevents peptidoglycan cross-linking by binding to penicillin-
                                      binding protein 3. Synergistic with aminoglycosides. No cross-allergenicity with penicillins.

                cliNical Use         Gram ⊝ rods only—no activity against gram ⊕ rods or anaerobes. For penicillin-allergic patients
                                       and those with renal insufficiency who cannot tolerate aminoglycosides.
                aDVerse eFFects      Usually nontoxic; occasional GI upset.



               Vancomycin
                mecHaNism            Inhibits cell wall peptidoglycan formation by binding D-Ala-D-Ala portion of cell wall precursors.
                                       Bactericidal against most bacteria (bacteriostatic against C difficile). Not susceptible to
                                       β-lactamases.

                cliNical Use         Gram ⊕ bugs only—for serious, multidrug-resistant organisms, including MRSA, S epidermidis,
                                      sensitive Enterococcus species, and Clostridium difficile (oral dose for pseudomembranous colitis).
                aDVerse eFFects      Well tolerated in general but NOT trouble Free.
                                     Nephrotoxicity, Ototoxicity, Thrombophlebitis, diffuse Flushing (red man syndrome  A  idiopathic
                A
                                       reaction largely preventable by pretreatment with antihistamines), DRESS syndrome.









                mecHaNism oF resistaNce  Occurs in bacteria (eg, Enterococcus) via amino acid modification of D-Ala-D-Ala to D-Ala-D-Lac.
                                       “If you Lack a D-Ala (dollar), you can’t ride the van (vancomycin).”
















          FAS1_2019_03-Microbiology.indd   190                                                                         11/14/19   12:22 PM
   229   230   231   232   233   234   235   236   237   238   239